3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
15
Lymphoma, Follicular
10
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Breast Neoplasms
5
Waldenstrom Macroglobulinemia
4
Myelodysplastic Syndromes
4
Mycosis Fungoides
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia
4
Sezary Syndrome
3
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Neoplasms
2
Melanoma
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Liver Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
Doxorubicin
6
Vincristine
4
Dexrazoxane
4
Razoxane
3
Radiotherapy
2
Prednisone
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Exercise
2
Etoposide
2
Cyclophosphamide
2
Bleomycin
2
pegfilgrastim
1
hydrocortisone hemisuccinate
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Secondary Prevention
1
Rituximab
1
Pulse Wave Analysis
1
Prednisolone
1
Nebivolol
1
Methotrexate
1
Methods
1
Mercaptopurine
1
Leucovorin
1
Lenalidomide
1
Hydrocortisone
1
Electrocardiography
1
Echocardiography
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Blood Specimen Collection
×
Lymphoid
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled